Beleave Inc.
BLEVFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$566
P/E Ratio—
52W High$0.0001
52W Low$0.000001
Beleave Inc. (BLEVF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BLEVF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2019Report Date: Dec 31, 2019EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2019
FY ends December
Report Date
Dec 31, 2019
After Market Close
BLEVF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2019 | Dec 31, 2019 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2019 | Sep 30, 2019 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2019 | Jun 30, 2019 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2019 | Mar 31, 2019 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2018 | Dec 31, 2018 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2018 | Nov 29, 2018 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2018 | Aug 29, 2018 | — | -$0.04 | — | $0.00B | — | — |
| — Q3 FY2018 | Jul 31, 2018 | — | -$0.02 | — | — | — | — |
Q4 FY2019
Dec 31, 2019
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2019
Sep 30, 2019
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2019
Jun 30, 2019
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2019
Mar 31, 2019
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2018
Dec 31, 2018
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2018
Nov 29, 2018
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2018
Aug 29, 2018
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2018
Jul 31, 2018
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for BLEVF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2019 | Dec 31, 2019 | — | $0.01 | $0.01 | -36.67% |
| — Q3 FY2019 | Sep 30, 2019 | — | $0.03 | $0.03 | -9.63% |
| — Q2 FY2019 | Jun 30, 2019 | — | $0.07 | $0.06 | -7.45% |
| — Q1 FY2019 | Mar 31, 2019 | — | $0.06 | $0.06 | -3.17% |
| — Q4 FY2018 | Dec 31, 2018 | — | $0.07 | $0.08 | +10.44% |
| — Q4 FY2018 | Nov 29, 2018 | — | $0.11 | $0.11 | +3.54% |
| — Q3 FY2018 | Aug 29, 2018 | — | $0.17 | $0.18 | +7.68% |
| — Q3 FY2018 | Jul 31, 2018 | — | $0.13 | $0.13 | -1.47% |
Q4 FY2019-36.67%
Report Date
Dec 31, 2019
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2019-9.63%
Report Date
Sep 30, 2019
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2019-7.45%
Report Date
Jun 30, 2019
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.06
Q1 FY2019-3.17%
Report Date
Mar 31, 2019
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q4 FY2018+10.44%
Report Date
Dec 31, 2018
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.08
Q4 FY2018+3.54%
Report Date
Nov 29, 2018
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.11
Q3 FY2018+7.68%
Report Date
Aug 29, 2018
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.18
Q3 FY2018-1.47%
Report Date
Jul 31, 2018
EPS Beat/Miss
—
Price Before
$0.13
Price After
$0.13
Beat Rate0 / 8 quarters
Largest Move-36.67% (Q4 FY2019)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BLEVF ends December
Beleave Inc. (BLEVF) most recently reported earnings on December 31, 2019 for Q4 FY2019, posting EPS of $-0.00 (in line with the analyst consensus of —). The next BLEVF earnings date is expected around September 1, 2026.
Each quarter, investors track BLEVF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLEVF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BLEVF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BLEVF earnings · 4 questionsBeleave Inc.'s next earnings report is expected around September 1, 2026. BLEVF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLEVF historically reports after market close (AMC).
BLEVF earnings datewhen is BLEVF earningsBLEVF next earnings datewhen does BLEVF report earningsBLEVF earnings calendar
▸ Source: FMP · Beleave Inc. SEC filings · US GAAP · Beleave Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026